Dietary cholesterol is transported from the intestine to the liver by:
What is the primary role of Cytochrome P450 enzymes in the liver?
In type I diabetes, which of the following is the MOST characteristic metabolic change that distinguishes it from type II diabetes:-
Ammonia in brain is trapped by
Which of the following statements about LDL is false?
Which of the following statements about gluconeogenesis is true?
What happens to glucose consumed in a soft drink by a 19-year-old athlete during a track event?
Ketone body formation without glycosuria is seen in ?
Which of the following is not a ketone body produced by the liver?
Which enzyme deficiency is responsible for Hyperammonemia type-1?
Explanation: ***Apo-B*** - **Apolipoprotein B-48** (Apo-B48) is the key structural protein of **chylomicrons**, which are large lipoprotein particles formed in intestinal enterocytes. - Chylomicrons are responsible for transporting **dietary triglycerides** and **cholesterol** from the intestine via the lymphatic system into the bloodstream and ultimately to the liver. - Apo-B48 is essential for chylomicron assembly and secretion from the intestine. *Apo-A* - **Apolipoprotein A-I** (ApoA-I) is the primary apolipoprotein of **high-density lipoprotein (HDL)**. - HDL is mainly involved in **reverse cholesterol transport**, moving cholesterol from peripheral tissues back to the liver. *Apo-C* - **Apolipoprotein C-II** (ApoC-II) is an activator of **lipoprotein lipase (LPL)**, which metabolizes triglycerides in chylomicrons and VLDL. - **Apolipoprotein C-III** (ApoC-III) inhibits LPL activity and hepatic uptake of triglyceride-rich lipoproteins. *Apo-E* - **Apolipoprotein E** (ApoE) is crucial for the receptor-mediated uptake of **chylomicron remnants** and **VLDL remnants** by the liver. - While involved in remnant clearance, it is not the primary apolipoprotein for the initial transport of dietary cholesterol from the intestine within intact chylomicrons.
Explanation: ***Oxidation of drugs*** - **Cytochrome P450 enzymes** are a superfamily of monooxygenases that primarily catalyze the **oxidation of various endogenous and exogenous substrates**, including drugs [1, 2]. - This oxidative metabolism is a key step in detoxification and elimination of foreign compounds from the body [1]. *Lipid transport* - **Lipid transport** is primarily facilitated by **lipoproteins** and specific **transport proteins** in the blood and within cells. - While P450 enzymes can metabolize some lipids, their primary role is not in lipid transport [2]. *Carbohydrate synthesis* - **Carbohydrate synthesis**, or **gluconeogenesis**, is mainly carried out by enzymes such as **pyruvate carboxylase** and **fructose-1,6-bisphosphatase**. - Cytochrome P450 enzymes do not play a direct role in the synthesis of carbohydrates. *Protein degradation* - **Protein degradation** is largely mediated by the **ubiquitin-proteasome system** and **lysosomal pathways**. - Cytochrome P450 enzymes are not directly involved in breaking down proteins into smaller peptides or amino acids.
Explanation: ***Increased lipolysis*** - In **type 1 diabetes** (T1D), there is an **absolute deficiency of insulin**, which is a potent **anti-lipolytic hormone**. [1] - This lack of insulin leads to unopposed **lipolysis**, resulting in increased free fatty acid (FFA) release, which can be metabolized into **ketone bodies** and contribute to **diabetic ketoacidosis (DKA)**. [2] *Increased protein catabolism* - While protein catabolism is increased in uncontrolled T1D due to the lack of insulin and increased counter-regulatory hormones, it is not the *most characteristic* metabolic change that clearly distinguishes it from type 2 diabetes (T2D), especially in early stages of T2D where some insulin may still be present. [1] - **Protein breakdown** produces amino acids for gluconeogenesis, contributing to hyperglycemia, but **lipolysis leading to ketosis** is more specific to severe insulin deficiency. [3] *Decreased glucose uptake* - **Decreased glucose uptake** by peripheral tissues (especially muscle and adipose tissue) is a characteristic feature of both T1D and T2D. [1] - In T1D, it's due to insulin deficiency, while in T2D, it's primarily caused by **insulin resistance**, making it less specific to distinguish T1D. *Increased hepatic glucose output* - **Increased hepatic glucose output** is a significant contributor to hyperglycemia in both T1D and T2D. [1] - In T1D, it's due to the lack of insulin's suppressive effect on the liver, whereas in T2D, it's due to **hepatic insulin resistance** and increased gluconeogenesis.
Explanation: ***Glutamine*** - Ammonia in the brain is primarily detoxified by its conversion to **glutamine** through the enzyme **glutamine synthetase**. - This reaction combines **ammonia** with **glutamate**, effectively trapping the toxic ammonia in a non-toxic form that can be transported out of the brain. *Alanine* - **Alanine** plays a role in ammonia transport within the **glucose-alanine cycle** between muscle and liver, but it is not the primary mechanism for trapping ammonia in the brain. - While it can be formed from pyruvate and glutamate, its formation is not the main brain ammonia detoxification pathway. *Aspartate* - **Aspartate** is involved in the urea cycle and as a neurotransmitter, but it does not directly trap free ammonia in the brain. - It participates in transamination reactions with alpha-ketoglutarate, forming oxaloacetate and glutamate, but this isn't the main ammonia trapping mechanism. *Ornithine* - **Ornithine** is a key intermediate in the **urea cycle**, which primarily occurs in the liver for the detoxification of ammonia. - It is not directly involved in trapping ammonia within the brain tissue itself.
Explanation: ***Transports maximum amount of lipid*** - This statement is false because **chylomicrons**, not LDL, are primarily responsible for transporting the **maximum amount of dietary lipids** (triglycerides) from the intestines to various tissues. - While LDL does transport lipids, its primary role is to deliver **cholesterol** to cells, and it contains a lower proportion of triglyceride compared to chylomicrons and VLDL. *More dense than chylomicron* - This statement is true; **LDL is denser than chylomicrons** because it has a higher protein-to-lipid ratio. - **Chylomicrons** are the least dense lipoproteins due to their very high triglyceride content. *Smaller than VLDL* - This statement is true; **LDL is smaller than VLDL** (Very Low-Density Lipoprotein). - VLDL particles are larger and contain more triglycerides, which are gradually removed, leading to the formation of smaller LDL particles. *Contains maximum cholesterol* - This statement is true; **LDL contains the highest proportion of cholesterol** (specifically, **cholesterol esters**) among the lipoproteins. - This characteristic makes LDL the primary carrier for delivering cholesterol to peripheral tissues.
Explanation: ***Uses ATP*** - Gluconeogenesis is an **anabolic process** that synthesizes glucose from non-carbohydrate precursors, requiring significant energy input in the form of **6 ATP and 2 GTP molecules per glucose molecule**. - Key energy-consuming reactions include **pyruvate carboxylase** (uses ATP) and **phosphoenolpyruvate carboxykinase (PEPCK)** (uses GTP). - This high energy requirement distinguishes it from glycolysis, which produces ATP. *Occurs only in liver* - This is **incorrect** as gluconeogenesis occurs predominantly in the **liver (90%)** but also takes place in the **renal cortex (10%)** and to a minimal extent in the epithelial cells of the small intestine. - The liver's role is crucial for maintaining **blood glucose homeostasis** during fasting or starvation. *Activated by insulin* - Gluconeogenesis is **inhibited by insulin**, which signals a state of high blood glucose and promotes glucose utilization and storage. - It is primarily **activated by glucagon and cortisol**, hormones that signal low blood glucose and energy deficit states. *Uses only lactate as a substrate* - This is **incorrect** as gluconeogenesis utilizes multiple substrates, not just lactate. - Key substrates include **lactate** (via the Cori cycle), **amino acids** (especially alanine via the glucose-alanine cycle), **glycerol** (from lipolysis), and **propionate**. - This substrate diversity allows glucose production from various metabolic pathways during fasting.
Explanation: ***Correct: Muscles will primarily use glucose for immediate energy production.*** - During intense exercise like a track event, **skeletal muscles** are the primary consumers of circulating glucose for immediate ATP production through glycolysis and oxidative phosphorylation. - The glucose from the soft drink provides readily available fuel for the working muscles, meeting their acute energy demands. - This direct utilization of exogenous glucose **spares muscle and liver glycogen stores**, which is metabolically advantageous during prolonged exercise. - The high rate of glucose uptake by exercising muscle is facilitated by **GLUT4 translocation** to the cell membrane, which occurs independent of insulin during muscle contraction. *Incorrect: Hexokinase helps convert glucose to energy quickly during exercise.* - While hexokinase does phosphorylate glucose to glucose-6-phosphate (the first step of glycolysis), this statement is too mechanistic and doesn't describe the **physiologic fate** of consumed glucose. - The question asks "what happens" in the context of exercise, requiring an answer about tissue-level glucose utilization, not just enzymatic steps. *Incorrect: The glucose from the soda will be stored as glycogen in the liver.* - Glycogen storage occurs in the **fed, resting state** when energy demands are low and insulin levels are high. - During a track event, the body's immediate energy requirements are elevated, and glucose is preferentially oxidized for fuel rather than stored. - Glycogen synthesis would occur during the **recovery phase** after exercise, not during the event itself. *Incorrect: Glucose will be used by both muscles and liver.* - While technically true that both tissues can utilize glucose, this answer lacks precision about the **primary metabolic fate** during exercise. - The liver's main role during exercise is to **maintain blood glucose homeostasis** through glycogenolysis and gluconeogenesis, supplying glucose to the blood rather than consuming it. - During intense exercise, **skeletal muscle glucose uptake can increase 20-50 fold**, making it the predominant consumer of circulating glucose. - This option is too vague and doesn't capture the physiologic priority of muscle glucose utilization during a track event.
Explanation: ***Starvation*** - During **starvation**, the body depletes its **glycogen stores** and begins to break down **fat for energy**. This process leads to the production of **ketone bodies** (acetoacetate, beta-hydroxybutyrate, and acetone) as an alternative fuel source for the brain and other tissues. - Since there is no underlying problem with **insulin production** or action, blood glucose levels are typically low or normal, and therefore, **glycosuria** (glucose in the urine) is absent. *Diabetes mellitus* - In **uncontrolled diabetes mellitus**, especially Type 1, the body cannot effectively use **glucose** due to lack of insulin, leading to high blood glucose levels (**hyperglycemia**) and subsequently **glycosuria**. - The body then compensates by breaking down **fats**, leading to the formation of **ketone bodies** (**diabetic ketoacidosis**), which results in both **ketonuria** and **glycosuria**. *Diabetes insipidus* - **Diabetes insipidus** is a condition characterized by the inability to conserve water due to insufficient **antidiuretic hormone (ADH)** production or action, leading to excessive urination and thirst. - It does not involve abnormalities in **glucose metabolism** or **ketone body production** and therefore does not typically present with ketonuria or glycosuria. *Obesity* - While **obesity** can lead to **insulin resistance** and is a risk factor for Type 2 Diabetes, it does not directly cause **ketone body formation** in the absence of metabolic derangements such as those seen in uncontrolled diabetes or prolonged starvation. - In most cases of obesity without diabetes, **glucose metabolism** is still adequate enough to prevent significant reliance on **fat breakdown** for energy, meaning there is usually no ketonuria or glycosuria.
Explanation: ***Glycerol 3-phosphate*** - **Glycerol 3-phosphate** is a molecule involved in **triglyceride synthesis** and glycolysis, not a ketone body produced by the liver. - It is formed from **dihydroxyacetone phosphate** (a glycolysis intermediate) or by phosphorylation of **glycerol**. *β-hydroxybutyrate* - **β-hydroxybutyrate** is one of the primary **ketone bodies** produced by the liver. - It is formed from **acetoacetate** and is a major energy source during prolonged fasting or ketogenic states. *Acetoacetate* - **Acetoacetate** is a principal **ketone body** synthesized by the liver. - It is an intermediate formed during the breakdown of **fatty acids** and supplies energy to peripheral tissues. *Acetone* - **Acetone** is a ketone body that arises from the **spontaneous decarboxylation of acetoacetate**. - While produced by the liver, it is primarily **excreted through respiration** and is not used as an energy source by peripheral tissues.
Explanation: ***Carbamoyl phosphate synthetase I (CPS-1) deficiency*** - This enzyme deficiency is classified as **Hyperammonemia type-1**, or **CPS1 deficiency**, and results in the inability to initiate the urea cycle. - **CPS-1** catalyzes the first committed step of the urea cycle, combining ammonia and bicarbonate to form carbamoyl phosphate. *Arginase deficiency* - This deficiency causes **Hyperargininemia**, which is a disorder of the urea cycle distinct from Hyperammonemia type-1. - Arginase is involved in the final step of the urea cycle, converting arginine to urea and ornithine. *Arginosuccinate lyase deficiency* - This deficiency leads to **Argininosuccinic aciduria**, another urea cycle disorder. - **Arginosuccinate lyase** is responsible for breaking down argininosuccinate into arginine and fumarate. *Arginosuccinate synthase deficiency* - This deficiency causes **Citrullinemia type 1**, a metabolic disorder characterized by high levels of citrulline and ammonia. - **Arginosuccinate synthase** catalyzes the condensation of citrulline and aspartate to form argininosuccinate.
Get full access to all questions, explanations, and performance tracking.
Start For Free